StockIQ.techRevvity, Inc. (RVTY) Stock Analysis
Free AI-powered analysis and research for Revvity, Inc. stock
Sector: Healthcare
RVTY snapshot
Data as of 4 Nov 2026 close. Updated daily.
Revvity, Inc. scores 61/100 on StockIQ's model, which reads as positive signals overall. The price is above its 200-day average and at 87% of its 52-week range, up 74.6% over the past year. Latest reported figures show a profit margin of 8.2%, return on equity of 3.2% and revenue growth of +1.3%.
What is driving the score
- RSI Neutral: +5
- Strong Uptrend: +12
- MACD Bearish: -8
- High P/E (77.6): -10
- Weak ROE (3.2%): -6
- Strong Long-term Uptrend: +8
- Strong Rise (+74.6% over 1 year): +10
Automated, general information only – not financial advice. Scores can be wrong. How the score works
Full RVTY report
Revvity, Inc. (RVTY) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze RVTY Now →📰 Latest Update
Revvity Q3 Earnings Call Highlights
Wed, November 4, 2026 at 8:14 AM UTC 3 min read
Revvity (NYSE: RVTY) reported strong Q3 results, driven by robust demand in its Life Sciences segment and growth in Diagnostics, achieving 7% pro forma organic growth. The company generated pro forma adjusted earnings per share of $1.37, exceeding expectations, while Life Sciences revenue rose 11% to $380 million. Management highlighted the expanding impact of AI-related demand across its portfolio and noted that backlog increased across nearly every instrument category, prompting plans for capacity expansion.